1026600-20-3

Upstream product

• 1028302-47-7 4-(tert-Butyl-dimethyl-silanyloxymethyl)-8-ethyl-1-methoxymethoxy-naphthalene-2-carbaldehyde 
• 1027014-65-8 4-(tert-Butyl-dimethyl-silanyloxymethyl)-8-ethyl-1-methoxymethoxy-naphthalen-2-ol 
• 131421-59-5 (1,1-dimethylethyl)<<5-ethyl-4-(methoxymethoxy)-1-naphthalenyl>methoxy>dimethylsilane 
• 144272-85-5 5-ethyl-4-(methoxymethoxy)-1-naphthalenecarboxaldehyde 
• 1026041-63-3 (5-Ethyl-4-methoxymethoxy-naphthalen-1-yl)-methanol 
• 131421-48-2 5-ethyl-4-hydroxy-1-naphthalenecarboxaldehyde 
• 131421-20-0 8-hydroxy-α-methyl-1-naphthalenemethanol 
• 131421-87-9 8-ethyl-1-naphthalenol 
• 18528-55-7 1-(8-hydroxynaphthalen-1-yl)ethanone 
• 5247-85-8 1,8-naphtholactone 
• 144272-86-6 (1,1-dimethylethyl)<<5-ethyl-4-(methoxymethoxy)-3-(phenylmethoxy)-1-naphthalenyl>methoxy>dimethylsilane 

Downstream Products

• 1026272-21-8 (E)-3-(3-Benzyloxy-5-ethyl-4-methoxymethoxy-naphthalen-1-yl)-acrylic acid 
• 131421-60-8 5-ethyl-4-(methoxymethoxy)-3-(phenylmethoxy)-1-naphthalenecarboxaldehyde 

Relevant academic research and scientific papers

A novel orally active inhibitor of IL-1 generation: Synthesis and structure-activity relationships of 3-(4-hydroxy-1-naphthalenyl)-2-propenoic acid derivatives

A new series of 3-(4-hydroxy-1-naphthalenyl)-2-propenoic acids was prepared and the inhibitory activities of its members on IL-1 generation were evaluated both by in vitro systems using human monocytes and/or rat exudated macrophages stimulated with LPS,